Center-Authored Papers

Filters: Author is Press, Oliver  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhan J, Stayton P, Press OW.  1998.  Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation.. Cancer immunology, immunotherapy : CII. 46(1):55-60. Abstract
Zelenetz AD, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE, Glenn MJ et al..  2011.  Non-Hodgkin's lymphomas.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(5):484-560.
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Bellam N, Byrd JC, Czuczman MS et al..  2014.  Non-Hodgkin's Lymphomas, Version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(6):916-46. Abstract
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Czuczman MS, Fayad LE et al..  2014.  Non-Hodgkin's lymphomas, version 4.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(9):1282-303. Abstract
Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad LE et al..  2013.  Non-Hodgkin's lymphomas, version 1.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(3):257-72;quiz273. Abstract
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Fayad LE, Fisher RI et al..  2016.  Diffuse Large B-Cell Lymphoma Version 1.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(2):196-231. Abstract
Zelenetz AD, Abramson JS, Advani RH, Andreadis BC, Byrd JC, Czuczman MS, Fayad L, Forero A, Glenn MJ, Gockerman JP et al..  2010.  NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(3):288-334.
Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Bellam N, Byrd JC, Czuczman MS, Fayad L et al..  2012.  Non-Hodgkin's Lymphomas, version 3.2012.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(12):1487-98. Abstract
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Czuczman MS, Fayad LE et al..  2015.  Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(3):326-62. Abstract
Zaucha R, Gooley TA, Holmberg L, Gopal AK, Press OW, Maloney DG, Bensinger WI.  2008.  High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.. Leukemia & lymphoma. 49(10):1899-906. Abstract
Y
Yang Q, Parker CL, Lin Y, Press OW, Park SI, Lai SK.  2017.  Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigens.. Journal of controlled release : official journal of the Controlled Release Society. Abstract
W
Witzig TE, Fishkin P, Gordon LI, Gregory SA, Jacobs S, Macklis R, McLaughlin P, Press OW, Zelenetz AD.  2011.  Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report.. Leukemia & lymphoma. 52(7):1188-99. Abstract
Williams ME, Connors JM, Dreyling MH, Gascoyne RD, Kahl BS, Leonard JP, Press OW, Wilson WH.  2011.  Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.. Leukemia & lymphoma. 52(1):24-33. Abstract
Wilbur SD, Park SI, Chyan M-K, Wan F, Hamlin DK, Shenoi J, Lin Y, Wilbur SM, Buchegger F, Pantelias A et al..  2010.  Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.. Bioconjugate chemistry. 21(7):1225-38. Abstract
Wilbur SD, Thakar MS, Hamlin DK, Santos EB, Chyan M-K, Nakamae H, Pagel JM, Press OW, Sandmaier BM.  2009.  Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.. Bioconjugate chemistry. 20(10):1983-91. Abstract
Wilbur SD, Hamlin DK, Meyer DL, Mallett RW, Quinn J, Vessella RL, Press OW.  2002.  Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.. Bioconjugate chemistry. 13(3):611-20. Abstract
Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis BC, Bartlett N, Byrd JC, Caimi P, Fayad LE et al..  2017.  NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.. Journal of the National Comprehensive Cancer Network : JNCCN. 15(3):293-311. Abstract
Weinstock DM, Dalla-Favera R, Gascoyne RD, Leonard JP, Levy R, Lossos IS, Melnick AM, Nowakowski GS, Press OW, Savage KJ et al..  2015.  A roadmap for discovery and translation in lymphoma.. Blood. 125(13):2175-7.
Wang J, Jensen M, Lin Y, Sui X, Chen E, Lindgren CG, Till B, Raubitschek A, Forman SJ, Qian X et al..  2007.  Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains.. Human gene therapy. 18(8):712-25. Abstract
Wang J, Press OW, Lindgren CG, Greenberg P, Riddell S, Qian X, Laugen C, Raubitschek A, Forman SJ, Jensen MC.  2004.  Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(4):577-86. Abstract
Walter RB, Press OW, Pagel JM.  2010.  Pretargeted radioimmunotherapy for hematologic and other malignancies.. Cancer biotherapy & radiopharmaceuticals. 25(2):125-42. Abstract
Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK.  2005.  Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(15):3439-46. Abstract
V
Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T et al..  2013.  Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT C. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(13):1662-8. Abstract
U
Ulrickson M, Press OW, Casper C.  2012.  Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.. Advances in hematology. 2012:932658. Abstract
Ulrickson M, Okuku F, Walusansa V, Press O, Kalungi S, Wu D, Kambugu F, Casper C, Orem J.  2013.  Cutaneous T-cell lymphoma in sub-Saharan Africa.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(3):275-80. Abstract